News

Forty years of publicly funded trials added 14 million years of life for cancer patients and profoundly affected cancer care guidelines

A blood serum test can identify which patients have slow-growing disease that might be controlled with an aromatase inhibitor alone.

Study of federally funded research finds overall enrollment to treatment trials changed little, while enrollment to cancer control and prevention studies fell substantially.

Pretreatment fatigue can mean worse survival outcomes for patients with cancer

Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma

New Initiative Aims to Improve Representation in Cancer Clinical Trials